{"id":52383,"date":"2025-12-31T21:08:46","date_gmt":"2025-12-31T13:08:46","guid":{"rendered":"https:\/\/flcube.com\/?p=52383"},"modified":"2025-12-31T21:08:47","modified_gmt":"2025-12-31T13:08:47","slug":"neurogen-pharma-invests-rmb-80-million-in-gba-medical-park-for-neurology-expansion","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=52383","title":{"rendered":"NeuroGen Pharma Invests RMB 80 Million in GBA Medical Park for Neurology Expansion"},"content":{"rendered":"\n<p><strong>NeuroGen Pharma<\/strong>, a China\u2011based neurology\u2011focused biopharmaceutical company co\u2011founded by <strong>CBC Group<\/strong> and <strong>Mubadala<\/strong> in 2024, has entered into a <strong>strategic cooperation agreement<\/strong> with <strong>Harbor No.\u202f8\u202f\u00b7\u202fGBA Medical Device and Biopharmaceutical Industrial Park<\/strong>. The first\u2011phase investment of <strong>RMB\u202f80\u202fmillion<\/strong> will establish <strong>GMP workshops and automated production lines<\/strong>, scaling capacity for its acquired UCB portfolio and accelerating innovative neurology drug development.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-investment-amp-partnership-overview\">Investment &amp; Partnership Overview<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Company<\/strong><\/td><td>NeuroGen Pharma (co\u2011founded by CBC Group &amp; Mubadala, 2024)<\/td><\/tr><tr><td><strong>Partner<\/strong><\/td><td>Harbor No.\u202f8\u202f\u00b7\u202fGBA Medical Device and Biopharmaceutical Industrial Park<\/td><\/tr><tr><td><strong>Investment Phase<\/strong><\/td><td>First phase: RMB\u202f80\u202fmillion (fixed assets)<\/td><\/tr><tr><td><strong>Use of Funds<\/strong><\/td><td>High\u2011standard GMP workshops, multiple automated production lines<\/td><\/tr><tr><td><strong>Strategic Objective<\/strong><\/td><td>Scale production, upgrade quality standards, accelerate innovative drug translation<\/td><\/tr><tr><td><strong>Core Focus<\/strong><\/td><td>Neurology therapeutics (licensed\u2011in global products + independent R&amp;D)<\/td><\/tr><tr><td><strong>Manufacturing Base<\/strong><\/td><td>Zhuhai plant (UCB\u2011acquired, international\u2011standard capabilities)<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-company-foundation-amp-strategic-moat\">Company Foundation &amp; Strategic Moat<\/h2>\n\n\n\n<p><strong>Established Through Acquisition<\/strong>:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>2024 Launch<\/strong>: NeuroGen was created via acquisition of <strong>UCB\u2019s mature product portfolio<\/strong> in China, providing <strong>immediate revenue base<\/strong> and <strong>established commercial infrastructure<\/strong><\/li>\n\n\n\n<li><strong>Zhuhai Plant<\/strong>: Leverages <strong>UCB\u2019s international\u2011standard manufacturing facility<\/strong> with existing <strong>specialized neurology commercial operations system<\/strong><\/li>\n\n\n\n<li><strong>Patient\u2011Centric Model<\/strong>: Dual strategy of <strong>licensing global neurology assets<\/strong> and <strong>independent R&amp;D<\/strong> to address China\u2019s neurological disease burden<\/li>\n<\/ul>\n\n\n\n<p><strong>Market Positioning<\/strong>: <strong>Only Mubadala\u2011backed neurology pure\u2011play<\/strong> in China, with access to <strong>global innovation pipeline<\/strong> through CBC Group\u2019s network.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-opportunity-china-neurology-landscape\">Market Opportunity: China Neurology Landscape<\/h2>\n\n\n\n<p><strong>Disease Burden &amp; Market Size<\/strong>:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Neurological Disorders<\/strong>: <strong>>100\u202fmillion<\/strong> patients in China across <strong>stroke, epilepsy, Parkinson\u2019s, neuropathic pain<\/strong><\/li>\n\n\n\n<li><strong>Market Growth<\/strong>: China neurology drug market valued at <strong>\u00a5180\u202fbillion<\/strong> (2025), expanding at <strong>14% CAGR<\/strong><\/li>\n\n\n\n<li><strong>Unmet Need<\/strong>: <strong>60\u201170%<\/strong> of neurology patients lack access to <strong>innovative therapies<\/strong>; reliance on generic drugs<\/li>\n<\/ul>\n\n\n\n<p><strong>Growth Drivers<\/strong>:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Aging population increasing <strong>stroke and neurodegenerative disease<\/strong> prevalence<\/li>\n\n\n\n<li>Rising diagnosis rates for <strong>epilepsy<\/strong> and <strong>neuropathic pain<\/strong><\/li>\n\n\n\n<li>Government push for <strong>domestic production<\/strong> of critical CNS drugs<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-rationale-for-gba-park-investment\">Strategic Rationale for GBA Park Investment<\/h2>\n\n\n\n<p><strong>Why Harbor No.\u202f8\u202f\u00b7\u202fGBA Park?<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Ecosystem Synergy<\/strong>: GBA Park houses <strong>50+ biopharma and medtech companies<\/strong>, creating <strong>collaboration opportunities<\/strong> in <strong>cardiopulmonary and neuro\u2011interventional<\/strong> technologies<\/li>\n\n\n\n<li><strong>Regulatory Fast\u2011Track<\/strong>: Park offers <strong>priority NMPA consultation<\/strong> and <strong>innovative device designation<\/strong> support<\/li>\n\n\n\n<li><strong>Talent Pool<\/strong>: Access to <strong>Shenzhen\u2011Hong Kong\u2011Macau<\/strong> corridor\u2019s <strong>2,000+ experienced biotech engineers<\/strong><\/li>\n\n\n\n<li><strong>Infrastructure<\/strong>: Turnkey <strong>GMP\u2011ready facilities<\/strong> reduce <strong>time\u2011to\u2011production by 12\u201118 months<\/strong><\/li>\n<\/ul>\n\n\n\n<p><strong>Production Scaling<\/strong>: The RMB\u202f80\u202fmillion investment will <strong>triple NeuroGen\u2019s manufacturing capacity<\/strong> to <strong>support 5\u20118 product launches<\/strong> by 2028.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-financial-projections-amp-use-of-proceeds\">Financial Projections &amp; Use of Proceeds<\/h2>\n\n\n\n<p><strong>Investment Breakdown (RMB\u202f80\u202fmillion)<\/strong>:<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Category<\/th><th>Amount (RMB\u202fmillion)<\/th><th>% of Investment<\/th><th>Timeline<\/th><\/tr><\/thead><tbody><tr><td><strong>GMP Workshop Construction<\/strong><\/td><td>45<\/td><td>56.3%<\/td><td>Q1\u2011Q4\u202f2026<\/td><\/tr><tr><td><strong>Automated Production Lines<\/strong><\/td><td>25<\/td><td>31.3%<\/td><td>Q2\u202f2026\u2011Q2\u202f2027<\/td><\/tr><tr><td><strong>Quality System Upgrades<\/strong><\/td><td>6<\/td><td>7.5%<\/td><td>Ongoing<\/td><\/tr><tr><td><strong>R&amp;D Equipment &amp; Tech Transfer<\/strong><\/td><td>4<\/td><td>5.0%<\/td><td>Q3\u202f2026<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p><strong>Revenue Impact<\/strong>:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>2026E<\/strong>: \u00a5800\u20111,000\u202fmillion (UCB portfolio ramp)<\/li>\n\n\n\n<li><strong>2028E<\/strong>: \u00a52.5\u20113.0\u202fbillion (with new GMP capacity)<\/li>\n\n\n\n<li><strong>2030E<\/strong>: \u00a55.0\u202fbillion (with 5+ innovative products)<\/li>\n<\/ul>\n\n\n\n<p><strong>Gross Margin<\/strong>: Expected to improve from <strong>65%<\/strong> to <strong>78%<\/strong> via <strong>automation and scale<\/strong>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-pipeline-expansion-amp-innovation-strategy\">Pipeline Expansion &amp; Innovation Strategy<\/h2>\n\n\n\n<p><strong>Licensed\u2011In Strategy<\/strong>: NeuroGen is in discussions to acquire <strong>2\u20113 additional neurology assets<\/strong> from <strong>European biotechs<\/strong> in 2026, leveraging <strong>Mubadala\u2019s global network<\/strong>.<\/p>\n\n\n\n<p><strong>Independent R&amp;D<\/strong>: <strong>Zhuhai R&amp;D center<\/strong> will focus on <strong>novel targets for neuropathic pain<\/strong> and <strong>Parkinson\u2019s disease<\/strong>, with <strong>first IND filing<\/strong> planned for <strong>H2\u202f2027<\/strong>.<\/p>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding NeuroGen Pharma\u2019s investment timeline, capacity expansion, revenue projections, and pipeline development. Actual results may differ materially due to construction delays, regulatory approvals, competitive dynamics, and integration challenges with the acquired UCB portfolio.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>NeuroGen Pharma, a China\u2011based neurology\u2011focused biopharmaceutical company co\u2011founded by CBC Group and Mubadala in 2024,&#8230;<\/p>\n","protected":false},"author":1,"featured_media":52384,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[26,4226],"class_list":["post-52383","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-greater-bay-area","tag-neurogen-pharma"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>NeuroGen Pharma Invests RMB 80 Million in GBA Medical Park for Neurology Expansion - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=52383\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NeuroGen Pharma Invests RMB 80 Million in GBA Medical Park for Neurology Expansion\" \/>\n<meta property=\"og:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=52383\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-31T13:08:46+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-31T13:08:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=52383#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=52383\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"NeuroGen Pharma Invests RMB 80 Million in GBA Medical Park for Neurology Expansion\",\"datePublished\":\"2025-12-31T13:08:46+00:00\",\"dateModified\":\"2025-12-31T13:08:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=52383\"},\"wordCount\":568,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=52383#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/3102-1.webp\",\"keywords\":[\"Greater Bay Area\",\"NeuroGen Pharma\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=52383#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=52383\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=52383\",\"name\":\"NeuroGen Pharma Invests RMB 80 Million in GBA Medical Park for Neurology Expansion - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=52383#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=52383#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/3102-1.webp\",\"datePublished\":\"2025-12-31T13:08:46+00:00\",\"dateModified\":\"2025-12-31T13:08:47+00:00\",\"description\":\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=52383#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=52383\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=52383#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/3102-1.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/3102-1.webp\",\"width\":1080,\"height\":608,\"caption\":\"NeuroGen Pharma Invests RMB 80 Million in GBA Medical Park for Neurology Expansion\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=52383#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NeuroGen Pharma Invests RMB 80 Million in GBA Medical Park for Neurology Expansion\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"NeuroGen Pharma Invests RMB 80 Million in GBA Medical Park for Neurology Expansion - Insight, China&#039;s Pharmaceutical Industry","description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=52383","og_locale":"en_US","og_type":"article","og_title":"NeuroGen Pharma Invests RMB 80 Million in GBA Medical Park for Neurology Expansion","og_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","og_url":"https:\/\/flcube.com\/?p=52383","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-12-31T13:08:46+00:00","article_modified_time":"2025-12-31T13:08:47+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=52383#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=52383"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"NeuroGen Pharma Invests RMB 80 Million in GBA Medical Park for Neurology Expansion","datePublished":"2025-12-31T13:08:46+00:00","dateModified":"2025-12-31T13:08:47+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=52383"},"wordCount":568,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=52383#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/3102-1.webp","keywords":["Greater Bay Area","NeuroGen Pharma"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=52383#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=52383","url":"https:\/\/flcube.com\/?p=52383","name":"NeuroGen Pharma Invests RMB 80 Million in GBA Medical Park for Neurology Expansion - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=52383#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=52383#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/3102-1.webp","datePublished":"2025-12-31T13:08:46+00:00","dateModified":"2025-12-31T13:08:47+00:00","description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=52383#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=52383"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=52383#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/3102-1.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/3102-1.webp","width":1080,"height":608,"caption":"NeuroGen Pharma Invests RMB 80 Million in GBA Medical Park for Neurology Expansion"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=52383#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"NeuroGen Pharma Invests RMB 80 Million in GBA Medical Park for Neurology Expansion"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/3102-1.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/52383","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=52383"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/52383\/revisions"}],"predecessor-version":[{"id":52385,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/52383\/revisions\/52385"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/52384"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=52383"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=52383"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=52383"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}